Selected work

Publications

Peer-reviewed work spanning precision pharmacology, cystic fibrosis and inflammation-resolution biology.

2025Biomedicine & Pharmacotherapy

Development and application of a multimatrix LC–MS/MS method for quantifying elexacaftor–tezacaftor–ivacaftor: Expanding therapeutic drug monitoring in cystic fibrosis from systemic circulation to airways and sweat

Mucci M, Colarelli M, Ripani P, Di Nicola M, Del Ciotto M, Di Sabatino M, Collini F, Romano M, Recchiuti A.

PubMed ↗DOI ↗

2023FASEB Journal

Resolvin D1 improves airway inflammation and exercise capacity in cystic fibrosis lung disease

Ferri G, Serano M, Isopi E, Mucci M, Mattoscio D, Pecce R, Protasi F, Mall MA, Romano M, Recchiuti A.

PubMed ↗DOI ↗

2023Frontiers in Medicine

Maternal, newborn and breast milk concentrations of elexacaftor/tezacaftor/ivacaftor in a F508del heterozygous woman with cystic fibrosis following successful pregnancy

Ripani P, Mucci M, Pantano S, Di Sabatino M, Collini F, Ferri G, Romano M, Recchiuti A.

Full text ↗DOI ↗

Next step

We can import the full verified bibliography from PubMed/ORCID and automatically organize it by year and research area once you decide which record should be canonical.